Nasopharyngeal Cancer Outcomes From Saudi Arabia TO THE EDITOR:
In their recent article in Journal of Global Oncology, Al-Wassia et al 1 reported on the outcomes of Saudi Arabian patients with nasopharyngeal cancer treated with primarily neoadjuvant chemotherapy followed by concurrent chemoradiotherapy. We have a few questions about the study. On what basis were patients selected for neoadjuvant chemotherapy followed by concurrent chemoradiotherapy, neoadjuvant chemotherapy followed by radiotherapy, or concurrent chemoradiotherapy alone? Did any patients undergo resection of residual neck nodes after completion of therapy? How were the patients with relapse managed? 
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